Pacifica Partners’s AbbVie ABBV Stock Holding History

Pacifica Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$513K	Sell	1,973 -17	-0.9%	-$4.36K	0.15%	77
2026 Q2	$519K	Hold	1,990	–	–	0.16%	78
2026 Q1	$433K	Hold	1,990	–	–	0.14%	80
2025 Q4	$456K	Hold	1,990	–	–	0.2%	69
2025 Q3	$486K	Buy	1,990 +33	+2%	+$6.72K	0.17%	79
2025 Q2	$357K	Sell	1,957 -50	-2%	-$9.29K	0.14%	78
2025 Q1	$404K	Buy	2,007 +17	+0.9%	+$3.3K	0.18%	75
2024 Q4	$357K	Sell	1,990 -192	-9%	-$35.3K	0.15%	80
2024 Q3	$431K	Hold	2,182	–	–	0.18%	75
2024 Q2	$358K	Hold	2,182	–	–	0.15%	79
2024 Q1	$389K	Hold	2,182	–	–	0.17%	73
2023 Q4	$315K	Hold	2,182	–	–	0.16%	84
2023 Q3	$322K	Buy	2,182 +500	+30%	+$73.4K	0.18%	75
2023 Q2	$230K	Hold	1,682	–	–	0.13%	82
2023 Q1	$264K	Hold	1,682	–	–	0.16%	80
2022 Q4	$267K	Hold	1,682	–	–	0.18%	75
2022 Q3	$221K	Hold	1,682	–	–	0.16%	76
2022 Q2	$256K	Hold	1,682	–	–	0.18%	74
2022 Q1	$247K	Sell	1,682 -500	-23%	-$72.6K	0.16%	77
2021 Q4	$295K	Hold	2,182	–	–	0.19%	73
2021 Q3	$233K	Hold	2,182	–	–	0.17%	79
2021 Q2	$248K	Buy	2,182 +50	+2%	+$5.63K	0.19%	75
2021 Q1	$225K	Buy	2,132 +1,343	+170%	+$144K	0.19%	77
2020 Q4	$82K	Buy	789 +225	+40%	+$21.6K	0.08%	102
2020 Q3	$49K	Hold	564	–	–	0.05%	118
2020 Q2	$56K	Hold	564	–	–	0.06%	116
2020 Q1	$42K	Hold	564	–	–	0.05%	130
2019 Q4	$50K	Buy	+564	New	+$46.8K	0.05%	130

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Pacifica Partners's ABBV Position: Q3 2026 in Review

Pacifica Partners reduced its AbbVie (ABBV) stake by 0.85% in Q3 2026, selling an estimated $4.36K and leaving 1,973 shares worth $513K. The position accounts for 0.15% of the portfolio, ranked #77.

Pacifica Partners first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. The position peaked at $519K in Q2 2026. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Pacifica Partners held 1,973 shares of AbbVie worth $513K as of Q3 2026.
Pacifica Partners sold 17 AbbVie shares in Q3 2026, an estimated $4.36K.
AbbVie made up 0.15% of Pacifica Partners's portfolio in Q3 2026, its #77 holding.
Pacifica Partners first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
Pacifica Partners's AbbVie position peaked at $519K in Q2 2026.
1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.